Stevanato Group (NYSE:STVN) Releases FY24 Earnings Guidance

Stevanato Group (NYSE:STVN) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of €0.47-0.49 for the period, compared to the consensus estimate of $0.48. The company issued revenue guidance of €1.09-1.11 billion, compared to the consensus revenue estimate of $1.09 billion. Stevanato Group also updated its FY 2024 guidance to 0.517-0.539 EPS.

Stevanato Group Stock Down 2.0 %

Shares of Stevanato Group stock traded down €0.45 ($0.49) during trading on Friday, reaching €22.27 ($24.47). The company’s stock had a trading volume of 8,573 shares, compared to its average volume of 508,422. The company has a 50-day simple moving average of €19.68 and a two-hundred day simple moving average of €20.33. Stevanato Group has a 1-year low of €16.56 ($18.20) and a 1-year high of €34.73 ($38.16). The company has a market cap of $6.58 billion, a price-to-earnings ratio of 48.34, a P/E/G ratio of 10.18 and a beta of 0.58. The company has a quick ratio of 1.13, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same period in the prior year, the business posted $0.16 EPS. Stevanato Group’s revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts forecast that Stevanato Group will post 0.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

STVN has been the subject of several research reports. Morgan Stanley lowered their price objective on shares of Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th. Citigroup lowered their price target on Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.